Erik T Askevold
Overview
Explore the profile of Erik T Askevold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gregersen I, Sandanger O, Askevold E, Sagen E, Yang K, Holm S, et al.
PLoS One
. 2017 Nov;
12(11):e0188387.
PMID: 29176764
Aim: Interleukin-27 (IL-27) is involved in different inflammatory diseases; however, its role in atherosclerosis is unclear. In this study we investigated the expression of IL-27 and its receptor in patients...
2.
Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy
Abraityte A, Lunde I, Askevold E, Michelsen A, Christensen G, Aukrust P, et al.
Sci Rep
. 2017 Jun;
7(1):3490.
PMID: 28615692
The Wingless (Wnt) pathway has been implicated in the pathogenesis of dilated cardiomyopathy (DCM). To explore the role of Wnt modulators Wnt5a and sFRP3 in DCM patients we analyzed the...
3.
Abraityte A, Vinge L, Askevold E, Lekva T, Michelsen A, Ranheim T, et al.
J Mol Med (Berl)
. 2017 Mar;
95(7):767-777.
PMID: 28357477
Key Messages: • Wnt5a is elevated in serum and myocardium of HF patients and is associated with measures of progressive HF. • In cardiac fibroblasts, Wnt5a upregulates interleukin (IL)-6 and...
4.
Ueland T, Caidahl K, Askevold E, Karlsson T, Hartford M, Aukrust P
Int J Cardiol
. 2015 Apr;
190:217-9.
PMID: 25920031
No abstract available.
5.
Finsen A, Ueland T, Sjaastad I, Ranheim T, Ahmed M, Dahl C, et al.
PLoS One
. 2014 Nov;
9(11):e112172.
PMID: 25398010
Background: CCL21 acting through CCR7, is termed a homeostatic chemokine. Based on its role in concerting immunological responses and its proposed involvement in tissue remodeling, we hypothesized that this chemokine...
6.
Ueland T, Gullestad L, Nymo S, Yndestad A, Aukrust P, Askevold E
Clin Chim Acta
. 2014 Sep;
443:71-7.
PMID: 25199849
Inflammation has been implicated in the pathogenesis of heart failure (HF). In addition to their direct involvement as mediators in the pathogenesis of HF, inflammatory cytokines and related mediators could...
7.
Broch K, Askevold E, Gjertsen E, Ueland T, Yndestad A, Godang K, et al.
PLoS One
. 2014 Mar;
9(2):e89732.
PMID: 24586994
Background: Dilated cardiomyopathy is characterized by left ventricular dilatation and dysfunction. Inflammation and adverse remodeling of the extracellular matrix may be involved in the pathogenesis. Statins reduce levels of low...
8.
Gravning J, Askevold E, Nymo S, Ueland T, Wikstrand J, McMurray J, et al.
Circ Heart Fail
. 2013 Nov;
7(1):96-103.
PMID: 24284025
Background: The incremental prognostic value of high-sensitive troponin T (hs-cTnT) in heart failure (HF) beyond that of high-sensitivity C-reactive protein and amino-terminal probrain natriuretic peptide is debated. We examined the...
9.
Gregersen I, Skjelland M, Holm S, Holven K, Krogh-Sorensen K, Russell D, et al.
PLoS One
. 2013 Sep;
8(8):e72769.
PMID: 24023645
Objective: Atherosclerosis is a chronic inflammatory disorder that involves a range of inflammatory mediators. Although interleukin (IL)-9 has been related to inflammation, there are at present no data on its...
10.
Nymo S, Hulthe J, Ueland T, McMurray J, Wikstrand J, Askevold E, et al.
Eur J Heart Fail
. 2013 Aug;
16(1):68-75.
PMID: 23918775
Aim: We investigated the ability of prototypical inflammatory cytokines to predict clinical outcomes in a large population of patients with chronic systolic heart failure (HF). Methods And Results: Serum levels...